Cargando…

Portal Hypertension in Nonalcoholic Fatty Liver Disease: From Pathogenesis to Clinical Practice

Portal hypertension in nonalcoholic fatty liver disease (NAFLD) mostly occur in cirrhotic stage. However, several experimental and clinical studies showed evidence of portal hypertension in NAFLD without significant or advance fibrosis. This early development of portal hypertension in NAFLD is assoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nababan, Saut Horas H., Lesmana, Cosmas Rinaldi Adithya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547264/ https://www.ncbi.nlm.nih.gov/pubmed/36304507 http://dx.doi.org/10.14218/JCTH.2021.00593

Ejemplares similares

The Clinical Role of Endoscopic Ultrasound for Management of Bleeding Esophageal Varices in Liver Cirrhosis
por: Kalista, Kemal Fariz, et al.
Publicado: (2022)

Endoscopic ultrasound-guided portal pressure gradient measurement in managing portal hypertension
por: Lesmana, Cosmas Rinaldi Adithya
Publicado: (2023)

Technique innovation of endoscopic ultrasound portal pressure gradient measurement using standard manometer set for portal hypertension assessment
por: Lesmana, Cosmas Rinaldi Adithya
Publicado: (2022)

The Clinical Significance of Colon Polyp Pathology in Nonalcoholic Fatty Liver Disease (NAFLD) and Its Impact on Screening Colonoscopy in Daily Practice
por: Lesmana, Cosmas Rinaldi A., et al.
Publicado: (2020)

Portal Hypertension in Nonalcoholic Fatty Liver Disease: Challenges and Paradigms
por: Mitten, Emilie K., et al.
Publicado: (2023)

Predictive scoring systems for in-hospital mortality due to acutely decompensated liver cirrhosis in Indonesia
por: Nababan, Saut Horas H., et al.
Publicado: (2021)

The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms
por: JASIRWAN, Chyntia Olivia Maurine, et al.
Publicado: (2019)

A Novel Splenic Vein Flow Volume to the Portal Vein Flow Velocity Index as a Predictor for the Degree of Esophageal Varices in Liver Cirrhosis Patients
por: Wicaksono, Krishna Pandu, et al.
Publicado: (2022)

Impact of endoscopic ultrasound-guided radiofrequency ablation in managing pancreatic malignancy
por: Lesmana, Cosmas Rinaldi Adithya
Publicado: (2023)

Managing liver cirrhotic complications: Overview of esophageal and gastric varices
por: Lesmana, Cosmas Rinaldi Adithya, et al.
Publicado: (2020)

Scoring system for predicting 90-day mortality of in-hospital liver cirrhosis patients at Cipto Mangunkusumo Hospital
por: Hasan, Irsan, et al.
Publicado: (2023)

Clinical significance of isolated gastric varices in liver cirrhotic patients: A single‐referral‐centre retrospective cohort study
por: Lesmana, Cosmas Rinaldi A, et al.
Publicado: (2019)

Diagnostic Value of Neutrophil to Lymphocyte Ratio in Non-Alcoholic Fatty Liver Disease Evaluated Using Transient Elastography (TE) with Controlled Attenuated Parameter (CAP)
por: Lesmana, Cosmas Rinaldi Adithya, et al.
Publicado: (2022)

Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis
por: Pickett-Blakely, Octavia, et al.
Publicado: (2018)

Innovation of endoscopic management in difficult common bile duct stone in the era of laparoscopic surgery
por: Lesmana, Cosmas Rinaldi Adithya, et al.
Publicado: (2021)

MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Fang, Zhiqiang, et al.
Publicado: (2021)

Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: a large cross-sectional and prospective validation study
por: Lesmana, Cosmas Rinaldi A, et al.
Publicado: (2015)

Diagnostic Challenge in a Patient Presenting with Ascites and Hypergammaglobulinemia
por: Mustika, Syifa, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease: epidemiology, pathogenesis and therapeutic implications
por: Andronescu, Craita Isabela, et al.
Publicado: (2018)

Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases
por: Yu, Yao, et al.
Publicado: (2018)

Role of Steroid Hormones in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Yang, Meng, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis
por: Dorairaj, Vicneswarry, et al.
Publicado: (2021)

Intestinal Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Liu, Lu, et al.
Publicado: (2023)

Treatment Outcome of Endoscopic Ultrasound Radiofrequency Ablation for Incidentaloma Pancreatic Neuroendocrine Tumor in Young Female Patient: A 2-year Follow-Up
por: Lesmana, Cosmas Rinaldi Adithya, et al.
Publicado: (2022)

Therapeutic interventional endoscopic ultrasound in pancreato-biliary disorders: Does it really replace the surgical/percutaneous approach?
por: Lesmana, Cosmas Rinaldi Adithya, et al.
Publicado: (2021)

Gut Microbiota Profiles in Nonalcoholic Fatty Liver Disease and Its Possible Impact on Disease Progression Evaluated with Transient Elastography: Lesson Learnt from 60 Cases
por: Bastian, Winda P., et al.
Publicado: (2019)

Bedside Percutaneous Approach in a Critically Ill ICU Patient with Complex Pancreatobiliary Disorder Followed by Endoscopic Approach: Lessons Learnt from a Tertiary Referral Center
por: Lesmana, Cosmas Rinaldi Adithya, et al.
Publicado: (2021)

Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
por: Dongiovanni, Paola, et al.
Publicado: (2015)

Involvement of Periodontal Disease in the Pathogenesis and Exacerbation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: A Review
por: Kobayashi, Takashi, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease: Evolving paradigms
por: Lonardo, Amedeo, et al.
Publicado: (2017)

Role of Gut Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Dai, Xin, et al.
Publicado: (2015)

Update on pathogenesis, diagnostics and therapy of nonalcoholic fatty liver disease in children
por: Flisiak-Jackiewicz, Marta, et al.
Publicado: (2019)

Pathogenesis of and major animal models used for nonalcoholic fatty liver disease
por: Jiang, Mingzuo, et al.
Publicado: (2019)

Role of mitochondrial quality control in the pathogenesis of nonalcoholic fatty liver disease
por: Li, Ruibing, et al.
Publicado: (2020)

Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
por: Akhtar, Daud H., et al.
Publicado: (2019)

Experimental Data on the Role of Melatonin in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Terziev, Dimitar, et al.
Publicado: (2023)

Evaluation of Portal Venous Velocity with Doppler Ultrasound in Patients with Nonalcoholic Fatty Liver Disease
por: Ulusan, Serife, et al.
Publicado: (2011)

Endoscopic Management Using Novel Haemostatic Agents for Immediate Bleeding during Endoscopic Retrograde Cholangio-Pancreatography
por: Lesmana, Cosmas Rinaldi Adithya, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications
por: Lonardo, Amedeo, et al.
Publicado: (2022)

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
por: Tokushige, Katsutoshi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dga0vhgtrmipc6o8bo6m3o2pb8